
Nov 16, 2026 · 3 min read · Incretin Analogs
CagriSema REDEFINE 9: Phase 3b Results at Two Lower Doses
Phase 3b REDEFINE 9 (Lancet Diabetes & Endocrinology): about 21% mean weight change at 68 weeks vs 2.0% with placebo in 309 adults.
EvoX Biolabs sells research compounds for laboratory use only. You must be 21 or older to enter.
For research use only. Not for human or animal consumption.
For research use only. Not for human or animal consumption. Ships to US addresses only.

Nov 16, 2026 · 3 min read · Incretin Analogs
Phase 3b REDEFINE 9 (Lancet Diabetes & Endocrinology): about 21% mean weight change at 68 weeks vs 2.0% with placebo in 309 adults.